Lung Cancers Not Yet Recruiting Phase 1 Trials for Anlotinib (DB11885)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03910270Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung CancerTreatment